Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL521914 | 1.00 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL99596 | 0.97 | — | — | |
| SCHEMBL99597 | 0.97 | — | — | |
| SCHEMBL101534 | 0.97 | — | — | |
| SCHEMBL2253136 | 0.92 | — | — | |
| SCHEMBL2253133 | 0.92 | — | — | |
| SCHEMBL15940330 | 0.92 | — | — | |
| Methylamine SCHEMBL27938861 | 0.90 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL1504344 | 0.86 | — | — | |
| SCHEMBL2251117 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3835302-B1 | DIISOCYANATE COMPOUND HAVING ANHYDROSUGAR ALCOHOL CORE AND PREPARATION METHOD THEREFOR | SAMYANG CORP (KR) | 2024-10-02 | — | — | EP | claimed |
| US-12060364-B2 | Diisocyanate compound having anhydrosugar alcohol core and preparation method therefor | SAMYANG CORPORATION (KR) | 2024-08-13 | — | — | US | claimed |
| US-20210309670-A1 | DIISOCYANATE COMPOUND HAVING ANHYDROSUGAR ALCOHOL CORE AND PREPARATION METHOD THEREFOR | SAMYANG CORPORATION (KR) | 2021-10-07 | — | — | US | claimed |
| EP-3835302-A1 | DIISOCYANATE COMPOUND HAVING ANHYDROSUGAR ALCOHOL CORE AND PREPARATION METHOD THEREFOR | Samyang Corporation (KR) | 2021-06-16 | — | — | EP | claimed |
| US-4136077-A | REACTION PRODUCT OF OLEFINICALLY-UNSATURATED NITRILE AND A MONOOLEFINIC HYDROCARBON AS PLASTICIZER FOR CONJUGATED DIENE-UNSATURATED NITRILE RUBBER | PHILLIPS PETROLEUM COMPANY (US) | 1979-01-23 | — | — | US | claimed |
| US-20250215029-A1 | STAT MODULATORS AND USES THEREOF | RECLUDIX PHARMA, INC. | 2025-07-03 | — | — | US | disclosed |
| US-20250215030-A1 | STAT MODULATORS AND USES THEREOF | RECLUDIX PHARMA, INC. | 2025-07-03 | — | — | US | disclosed |
| US-20250179103-A1 | 6-OXODECAHYDROPYRROLO[1,2-A][1,5]DIAZOCINE AND 6-OXODECAHYDRO-4H-PYRROLO[2,1-D][1,5]THIAZOCINE DERIVATIVES AS STAT3 AND STAT6 MODULATORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | RECLUDIX PHARMA, INC. | 2025-06-05 | — | — | US | disclosed |
| EP-4499656-A1 | STAT MODULATORS AND USES THEREOF | Recludix Pharma, Inc. (US) | 2025-02-05 | — | — | EP | disclosed |
| CN-119301127-A | 6-Oxo-decahydro pyrrolo [1,2-a ] [1,5] diazocine and 6-oxo-decahydro-4H-pyrrolo [2,1-d ] [1,5] thiaazacine derivatives as modulators of STAT3 and STAT6 for the treatment of cancer and inflammatory conditions | 瑞克鲁迪克斯制药股份有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-119183453-A | STAT modulators and uses thereof | 瑞克鲁迪克斯制药股份有限公司 | 2024-12-24 | — | — | CN | disclosed |
| EP-4463459-A1 | STAT MODULATORS AND USES THEREOF | Recludix Pharma, Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| US-4218394-A | FROM UNSATURATED NITRILES AND OLEFINS | PHILLIPS PETROLEUM COMPANY (US) | 1980-08-19 | — | — | US | disclosed |
| US-4217303-A | UNSATURATED HYDROCARBON, ADDUCT, UNSATURATED DINITRILE, BY-PRODUCT INHIBITION | PHILLIPS PETROLEUM COMPANY (US) | 1980-08-12 | — | — | US | disclosed |
| US-4200586-A | Inhibiting the carbon-carbon double bond isomerization of substituted or unsubstituted hydrocarbon compounds | PHILLIPS PETROLEUM COMPANY (US) | 1980-04-29 | — | — | US | disclosed |
| US-4195155-A | Hydrogenated polynitrile mixture and use as epoxy hardener | PHILLIPS PETROLEUM COMPANY (US) | 1980-03-25 | — | — | US | disclosed |
| US-4136077-A | REACTION PRODUCT OF OLEFINICALLY-UNSATURATED NITRILE AND A MONOOLEFINIC HYDROCARBON AS PLASTICIZER FOR CONJUGATED DIENE-UNSATURATED NITRILE RUBBER | PHILLIPS PETROLEUM COMPANY (US) | 1979-01-23 | — | — | US | disclosed |
| US-4117002-A | PYROLYSIS OF HEAVIES FORMED IN PRODUCTION OF UNSATURATED DINITRILES | PHILLIPS PETROLEUM COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
| US-4117001-A | TO RECOVER STARTING MATERIALS | PHILLIPS PETROLEUM COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
| US-3985786-A | REACTING AN OLEFINICALLY UNSATURATED NITRILE, AN OLEFINIC HYDROCARBON AND THEIR MONOADDUCT IN WATER | PHILLIPS PETROLEUM COMPANY (US) | 1976-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250179103-A1 | 6-OXODECAHYDROPYRROLO[1,2-A][1,5]DIAZOCINE AND 6-OXODECAHYDRO-4H-PYRROLO[2,1-D][1,5]THIAZOCINE DERIVATIVES AS STAT3 AND STAT6 MODULATORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | STAT6, STAT3, STAT1 | ALDH1A1 531/4885 |
| US-20210309670-A1 | DIISOCYANATE COMPOUND HAVING ANHYDROSUGAR ALCOHOL CORE AND PREPARATION METHOD THEREFOR | ADH1C, DAD1, UGT8 | ALDH1A1 226/4885 |
| US-20250215030-A1 | STAT MODULATORS AND USES THEREOF | STAT6, STAT3, STAT5A | ALDH1A1 3030/4885 |
| US-20250215029-A1 | STAT MODULATORS AND USES THEREOF | STAT6, STAT3, STAT5A | ALDH1A1 2707/4885 |
| US-12060364-B2 | Diisocyanate compound having anhydrosugar alcohol core and preparation method therefor | ADH1C, DAD1, UGT8 | ALDH1A1 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.